References and Notes
<A NAME="RS14606ST-1">1</A>
Dembitsky VM.
Srebnik M.
Tetrahedon
2003,
59:
579
<A NAME="RS14606ST-2">2</A>
Jabbour A.
Steinberg D.
Dembitsky VM.
Moussaieff A.
Zaks B.
Srebnik M.
J. Med. Chem.
2004,
47:
2409
<A NAME="RS14606ST-3">3</A>
Bailey PJ.
Cousin G.
Snow GA.
White A.
Antimicrob. Agents Chemother.
1980,
17:
549
<A NAME="RS14606ST-4">4</A>
Dobrydneva Y.
Abelt CJ.
Dovel B.
Thadigiri CM.
Williams RL.
Blackmore PF.
Mol. Pharmacol.
2006,
69:
247
<A NAME="RS14606ST-5">5</A>
Velasco B.
Trujillo-Ferrara JG.
Fabila LH.
Miranda R.
Sánchez-Torres LE.
Life Sci.
2007,
80:
1007
<A NAME="RS14606ST-6">6</A>
Lang K,
Nuetzel K, and
Schubert F. inventors; German Patent 1130445.
; Chem. Abstr. 1963, 58, 1488a
<A NAME="RS14606ST-7">7</A>
Skoog IH.
J. Org. Chem.
1964,
29:
492
<A NAME="RS14606ST-8">8</A>
Shih-Hua T.
Kuo-Min C.
Shih-Lu T.
Chia-Chun L.
Shih-Lin C.
Chem. Abstr.
1967,
66:
37990m
<A NAME="RS14606ST-9">9</A>
Nefkens GHL.
Zwanenburg B.
Tetrahedron
1983,
39:
2995
<A NAME="RS14606ST-10">10</A>
Flückinger R.
Henson E.
Hess GM.
Gallop PM.
Biomed. Mass Spectrom.
1984,
11:
611
<A NAME="RS14606ST-11">11</A>
Strang CJ.
Henson E.
Okamoto Y.
Paz MA.
Gallop PM.
Anal. Biochem.
1989,
178:
276
<A NAME="RS14606ST-12">12</A>
Farfán N.
Silva D.
Santillan R.
Heteroat. Chem.
1993,
4:
533
<A NAME="RS14606ST-13">13</A>
Trujillo J.
Höpfl H.
Castillo D.
Santillan R.
Farfán N.
J. Organomet. Chem.
1998,
571:
21
<A NAME="RS14606ST-14">14</A>
Chremos GN.
Weidmann H.
Zimmerman HK.
J. Org. Chem.
1961,
26:
1683
<A NAME="RS14606ST-15">15</A>
Rettig SJ.
Trotter J.
Can. J. Chem.
1977,
55:
958
<A NAME="RS14606ST-16">16</A>
Typical procedure (Table 1, entry 1, 3a): Glycine (0.5g, 6.6 mmol) was dissolved in H2O (3 mL) and the pH was ad-justed to 8 with NaOH (5%, 2 mL). A solution of diphenyl-borinic
acid was prepared from 2-aminoethyl-diphenyl-borinate (1.59 g, 6.6 mmol) as described
in the literature.14 The solutions were mixed together and heated at reflux for 4 h. The solvent was evaporated
slowly and the product was filtered and washed with cold H2O and n-hexane, yielding 1.49 g of 3a (6.26 mmol, 94%).
<A NAME="RS14606ST-17">17</A>
Cytotoxicity in K-562 and HCT-15 cell lines, using the sulforhodamine B assay: Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.
T., Bokesh H., Kenney S., Boyd M.R.; J. Natl. Cancer Inst.; 1990, 82: 1107; 24 h after treatment, the treated and control cell cultures were fixed with
ice-cold 10% CCl3COOH for 30 min. The 96-well plates were washed in H2O and then sulforhodamine (SRB, 100 µL, 0.4%) dissolved in AcOH (1%) was added to
each well and left for 15 min. The SRB was removed, washed in AcOH (1%) and allowed
to air-dry. Then aqueous Tris base [tris(hydroxymethyl)aminoethane] (100 µL, 10 mM)
was added to each well to solubilize the cell-bound dye and the absorbance at 550
nm was measured. The results are expressed as a percentage of control cell growth.
<A NAME="RS14606ST-18">18</A>
2,2-Diphenyl-1,3,2-oxazaborolidin-5-one (3a): White solid; mp 241-243 °C (Lit. 242-245 °C); IR (KBr): 3428, 3243, 3074, 1720,
1604, 1434, 1302, 1217, 963, 702 cm-1; 1H NMR (DMSO-d
6
): δ = 7.35 (d, J = 7 Hz, 4 H), 7.22 (t, J = 7 Hz, 4 H), 7.16 (t, J = 7 Hz, 4 H), 7.07 (br t, 2 H, NH), 3.43 (t, J = 6 Hz, 2 H); 13C NMR (DMSO-d
6
): δ = 42.9, 126.1, 127.1, 131.0, 147.8, 172.5; 11B NMR (DMSO-d
6
): δ = +5.03; MS (EI): m/z = 239, 238, 162 (base peak), 161, 132, 104, 77.